These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8917086)

  • 21. Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3.
    Bosse F; Brodbeck J; Müller HW
    J Neurosci Res; 1999 Jan; 55(2):164-77. PubMed ID: 9972819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M; Berger P; Nave KA; Suter U
    Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines.
    Hühne K; Park O; Liehr T; Rautenstrauss B
    J Neurosci Res; 1999 Dec; 58(5):624-31. PubMed ID: 10561690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines.
    Huehne K; Rautenstrauss B
    Int J Mol Med; 2001 Jun; 7(6):669-75. PubMed ID: 11351283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of PMP22 expression in osteosarcoma.
    van Dartel M; Hulsebos TJ
    Cancer Genet Cytogenet; 2004 Jul; 152(2):113-8. PubMed ID: 15262428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination.
    Notterpek L; Snipes GJ; Shooter EM
    Glia; 1999 Feb; 25(4):358-69. PubMed ID: 10028918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Embryonic expression of epithelial membrane protein 1 in early neurons.
    Wulf P; Suter U
    Brain Res Dev Brain Res; 1999 Sep; 116(2):169-80. PubMed ID: 10521561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22.
    Ben-Porath I; Kozak CA; Benvenisty N
    Genomics; 1998 May; 49(3):443-7. PubMed ID: 9615230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family.
    Schiemann S; Rückels M; Engelholm LH; Schwirzke M; Brünner N; Weidle UH
    Anticancer Res; 1997; 17(1A):13-20. PubMed ID: 9066625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
    Naef R; Suter U
    Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins.
    Ben-Porath I; Benvenisty N
    Gene; 1996 Dec; 183(1-2):69-75. PubMed ID: 8996089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
    Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
    J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
    Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
    Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
    Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
    Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
    Kuhn G; Lie A; Wilms S; Müller HW
    Glia; 1993 Aug; 8(4):256-64. PubMed ID: 7691737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral myelin protein 22 is expressed in human central nervous system.
    Ohsawa Y; Murakami T; Miyazaki Y; Shirabe T; Sunada Y
    J Neurol Sci; 2006 Aug; 247(1):11-5. PubMed ID: 16626749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer.
    Wang YW; Cheng HL; Ding YR; Chou LH; Chow NH
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):199-211. PubMed ID: 28408326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.